HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.

David Hadley, William Hagopian, Edwin Liu, Jin-Xiong She, Olli Simell, Beena Akolkar, Anette-G Ziegler, Marian Rewers, Jeffrey P Krischer, Wei-Min Chen, Suna Onengut-Gumuscu, Teodorica L Bugawan, Stephen S Rich, Henry Erlich, Daniel Agardh

Research output: Contribution to journalArticlepeer-review

Abstract

Tissue transglutaminase autoantibodies (tTGAs) represent the first evidence of celiac disease (CD) development. Associations of HLA-DR3-DQA1*05:01-DQB1*02:01 (i.e., DR3-DQ2) and, to a lesser extent, DR4-DQA1*03:01-DQB1*03:02 (i.e., DR4-DQ8) with the risk of CD differ by country, consistent with additional genetic heterogeneity that further refines risk. Therefore, we examined human leukocyte antigen (HLA) factors other than DR3-DQ2 for their contribution to developing tTGAs.
Original languageEnglish
Pages (from-to)915-920
JournalAmerican Journal of Gastroenterology
Volume110
Issue number6
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Gastroenterology and Hepatology

Fingerprint

Dive into the research topics of 'HLA-DPB1*04:01 Protects Genetically Susceptible Children from Celiac Disease Autoimmunity in the TEDDY Study.'. Together they form a unique fingerprint.

Cite this